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Abstract 
Magnetic hyperthermia is a promising therapy for the localized treatment of cancer based on 
the exposure of magnetic nanoparticles to an external alternating magnetic field. In order to 
evaluate some of the mechanisms involved in the cellular damage caused by this treatment, 
two different 3D cell culture models were prepared using collagen, which is the most 
abundant protein of the extracellular matrix. The same amount of nanoparticles was added to 
cells either before or after their incorporation to the 3D structure. Therefore, in one model, 
particles were located only inside cells (In model), while the other one had particles both 
inside and outside cells (In&Out model).
In the In&Out model, the hyperthermia treatment facilitated the migration of the particles 
from the outer areas of the 3D structure to the inner parts, achieving a faster homogeneous 
distribution throughout the whole structure and allowing the particles to gain access to the 
inner cells. 
The cell death mechanism activated by the magnetic hyperthermia treatment was different in 
both models. Necrosis was observed in the In model while apoptosis in the In&Out model 24 
hours after the hyperthermia application. This was clearly correlated with the amount of 
nanoparticles located inside the cells. Thus, the combination of both 3D models allowed us to 
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2demonstrate two different roles of the magnetic particles during the hyperthermia treatment: 
i) The modulation of the cell death mechanism depending on the amount of intracellular 
particles, and ii) The disruption of the collagen matrix caused by the extracellular 
nanoparticles. 
Introduction 
Iron oxide magnetic nanoparticles (MNPs) are one of the most promising systems within the 
field of biomedicine and biotechnology.1-3 Their physico-chemical characteristics as well as 
their magnetic properties, provide unique opportunities for the development of a wide range 
of applications such as biosensors,4-5 controlled drug delivery systems,6-7 contrast agents for 
magnetic resonance imaging,8-9 or cancer therapies such as magnetic hyperthermia.10 
Magnetic hyperthermia (MH) has been particularly studied in recent years for the treatment 
of malignant tumours.11-13 It is widely known that cancer cells are more sensitive to heat than 
normal cells.14 MNPs act as localized heating sources in the region where they are situated 
when submitted to an alternating magnetic field (AMF).15 The local temperature increase in 
the tumour area induces cell death or alters the growth and differentiation of the cancer 
cells.16 At the same time, MH has been used to promote synergistic effects when combined 
with other conventional treatments. In particular, it has been shown that MH treatment makes 
the cells more sensitive to radiation or to the action of certain chemotherapeutic drugs.17-19 A 
possible explanation of this synergistic effect between heat and chemotherapy was given by 
Krawczyk et al. who demonstrated that mild hyperthermia conditions provoked the 
degradation of BRCA2, a protein involved in the homologous recombination, which is a 
DNA repair mechanism by which the double strands breaks are repaired. If the cells are 
deficient in this DNA repair mechanism they become more sensitive to drugs that induce 
DNA damage.20
The cell death mechanisms activated by the MH treatment and the relevant parameters that 
control the triggering of each mechanism are not completely known yet. The classical 
conception of two cell death routes, apoptosis and necrosis, which take place independently, 
has been already refuted. Besides, some classical postulates about these two cell death 
mechanisms have been progressively abandoned and replaced for new ideas. It is known that 
necrosis can take place in a regulated way, like apoptosis, and that the apoptotic cells can 
sometimes be recognized by the immune system and trigger an adaptive immune response, 
like necrosis. Nevertheless, it is crucial to be able to control the activation of either necrosis 
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3or apoptosis mechanisms and to try to control the pro-inflammatory immune response that 
could be sometimes negative for tumour treatments, as it involves non-desirable processes 
such as the tumour invasion or metastasis. 21-23
Currently, most of the in vitro studies that analyse the efficacy of the hyperthermia treatment 
are being performed in monolayer cell cultures.24-26 However, this traditional cell culture 
method, in two dimensions (2D), has essential limitations in terms of inter-cellular 
communication, cell microenvironment and cell spatial behaviour.27 Therefore, these 2D cell 
culture models cannot replicate the morphology and biochemical properties the cells have in 
the living organisms. They also lack the complex scenario that the MNPs face to reach the 
deeper areas of the tumours. One of the alternatives to solve these problems is the use of three 
dimensions (3D) cell culture models, such as spheroids, liquid spheres,28-29 or 3D scaffolds.30-
31 3D cell culture models are simple structures that mimic more accurately the tumour 
composition and structure32 providing a more realistic environment to evaluate the cellular 
response to a treatment 33. In addition, 3D cell culture models allow the production of a high 
number of identical replicas and provide a good alternative to perform preliminary tests 
before in vivo experimentation allowing the reduction of the number of animals needed. Until 
know, the number of studies using 3D cell culture models to evaluate the effect of magnetic 
hyperthermia is still scarce.34 These previous studies have mainly used spheroids as 3D cell 
cultures, a model that lacks the presence of extracellular matrix.
In this work, we have developed two 3D cell culture models based on the use of a collagen 
matrix to evaluate the efficacy of magnetic hyperthermia treatment in a murine 
macrophage/monocyte cell line (RAW 264.7). Collagen was selected because besides being 
one of the major components of the extracellular matrix (ECM), it also plays a crucial role in 
the tumour ECM.35 In particular, tumours with well-organized and highly interconnected 
collagen fibres display lower penetration of high-molecular-weight chemotherapeutic agents 
than those with disordered and loose collagen networks.36 37  Macrophages were chosen as 
model cells due to their known capacity of easily incorporating iron oxide nanoparticles.38 
This fact allowed working with a wide range of concentrations of nanoparticles inside the 
cells, which facilitated the study of the correlation between the amount of internalized 
particles and the cell death mechanism activated. The main difference between the two 
models is the moment in which MNPs are in contact with the cells along the 3D cell culture 
preparation protocol. In one model (In Model), cells in suspension are incubated with the 
particles and after washing away the MNPs that have not been internalized, the cells are 
transferred to form the 3D matrix, thus resulting in a homogeneous internalization of the 
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4MNPs amongst all the cells and also an exclusive intracellular location of the MNPs. The 
other model is based on the administration of the MNPs to the cells once they are already 
forming part of the 3D matrix resulting in a model where particles need time to penetrate and 
fill up the whole 3D matrix to gain access to inner cells. As a result, this model allows 
obtaining a different MNP distribution than the former approach, having particles located 
both inside and outside the cells (In&Out Model) (Fig. 1).  The combination of both models 
allows disentangling the effect that MNPs have on the extracellular matrix and the treatment 
efficiency. 
In this work, we have used confocal microscopy and flow cytometry to study the MNP 
uptake, with and without exposure to an AMF. We have studied the evolution of the MNP 
location within the collagen matrix after the AMF exposure. We have also evaluated the cell 
death mechanisms triggered by the treatment at different times post-treatment (0, 24 and 48 
h). Cell cycle and the cell viability studies allowed to discriminate the cell death mechanisms 
observed 24 h after MH treatment which was different on each 3D model: necrosis for the In 
Mode and apoptosis in the case of the In&Out Model. Besides, we have analysed the amount 
of MNPs internalized in each 3D model in order to establish a relationship between their 
concentration and the cell death mechanism observed after the treatment. 
Page 4 of 43
ACS Paragon Plus Environment
ACS Applied Materials & Interfaces
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
5Fig. 1. Representation of the formation of the two 3D models used in this work. In Model, 
where the MNPs are located just inside the cells. In&Out Model, where MNPs are located 
both inside and outside the cells. 
Results and discussion
We have chosen spherical 11 nm iron oxide MNPs (11.2 ± 0.8 nm, Fig. 2), as this diameter is 
within the most commonly studied range for in vivo magnetic hyperthermia experiments.39 
This diameter fulfils the requirements for in vivo experimentation, as it avoids fast renal 
clearance. This size is also considered to be in the range to achieve the better heating 
properties for magnetite/maghemite.40
MNPs have been prepared by thermal decomposition to have a careful control of the particle 
size and size distribution (Fig. 2). The superparamagnetic behaviour at room temperature, 
desired in many biomedical applications to prevent the MNP aggregation associated to a 
permanent magnetic moment,1 has been verified by magnetic measurements confirming the 
negligible coercivity and also indicating the good crystalline properties of the prepared 
material by a high saturation magnetization (Ms = 81 Am2/kg Fe3O4) (Fig. 1).
Fig. 2. Magnetic nanoparticle characterization. (A) TEM micrograph, (B) Particle size 
distribution analysis and (C) Field dependent magnetization of the MNPs in water.
MNPs have been subsequently coated with a polymer (PMAO, poly (maleic anhydride-alt-1-
octadecene) modified with a fluorophore (TAMRA, Carboxytetramethylrhodamine). The 
polymer coating allows the transference of the magnetic cores from the organic to the 
aqueous phase and provides carboxylic groups that allow both the incorporation of the 
fluorophore, to track the location of the MNPs in the in vitro experiments, and glucose, to 
prevent the aggregation in cell culture medium and provide an active targeting molecule for 
the particles uptake.41 Glucose is especially interesting in our case as macrophages, as well as 
Page 5 of 43
ACS Paragon Plus Environment
ACS Applied Materials & Interfaces
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
6many tumour cells, due to their high energy requirements present upregulated glucose 
transporter proteins and subsequently the uptake of glucose-functionalized MNPs is 
enhanced.42 The successful glucose functionalization, routinely used in our lab, 43 has been 
verified by ζ – potential measurements through a significant decrease of the MNP negative 
charge from -36 mV, before functionalization, to -13 mV after the glucose addition. 
Several tests have been performed to assure that the material was suitable for in vitro 
experiments. Stability of functionalized MNPs has been assessed by Dynamic Light 
Scattering (DLS) measurements, showing that the hydrodynamic size of the particles before 
and after the glucose functionalization remains below 70 nm for MNPs at pH = 7, suspended 
both in water and complete culture medium (with 10% Foetal Bovine Serum) (Table. S1, 
Supporting Information). In addition, a sterility assay was performed and no evidence of the 
presence of microbial colonies has been observed after performing the test with the MNPs 
(Fig. S1, Supporting Information). Finally, although the low toxicity of particles prepared 
following the same protocol has already been checked in the past,44-45 cell viability after the 
MNP administration was studied by flow cytometry in 2D cell culture models at different 
concentrations up to 100 μg of Fe per well (200 μg/ml), observing only a significant 
reduction of the cell viability at the highest concentration (Fig. S2, Supporting Information). 
From these results, an iron amount of 100 μg of Fe per well has been chosen for the 
hyperthermia experiments, as it is the highest concentration tested in which the viability is 
not significantly different to the controls. The low toxicity of this amount of MNPs has also 
been confirmed by flow cytometry in the 3D cell cultures (Fig. S3, Supporting Information).
The heating efficiency of the MNPs in water suspensions has been evaluated before the in 
vitro test. The Specific Absorption Rate (SAR) of the MNPs measured at an iron 
concentration of 1 mg/mL and using a field amplitude of H = 20 kA/m, and a frequency of 
829 kHz is 253 W/g Fe. Establishing a correlation between the heating capacity of the MNPs 
in suspension and their ability to heat efficiently in in vitro experiments is not 
straightforward. First, it is difficult to determine and mimic the aggregation degree of the 
MNPs in the cellular environment. It is also a complex task to know the local concentration 
of the MNPs once they have been internalized by the cells. However, until all these problems 
are solved, the most common approach to validate that a specific material produces heat in 
the presence of an AMF is to measure the change of temperature over time in water at 
physiological pH, as at least it provides some information for comparison with other reported 
values. 
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7Two different 3D cell culture models have been developed. To achieve the generation of 
two 3D cell culture models we have followed two different strategies for the incubation of the 
cells with magnetic nanoparticles. As a proof of concept, macrophages have been selected as 
a model cell line, as they are known to easily uptake this kind of particles.38, 46 
The first approach followed has been to incubate the detached macrophages with the MNPs 
and, after removal of the particles that were not internalized, to form the 3D cell culture with 
the cells containing the MNPs. This approach leads to a 3D cell culture in which the MNPs 
are homogeneously distributed amongst all the cells and only located inside them (In Model), 
as observed by confocal microscopy and flow cytometry (Fig. 3), showing that almost all the 
cells (> 99%) contained MNPs after 1 h of incubation time. 
The second approach has been to embed the macrophages within the 3D structure and then 
administer the MNPs. This way, particles need more time to penetrate the collagen structure 
to reach the inner cells. Although, after the incubation time, the supernatant is removed and 
the 3D structure is washed, some MNPs remain within the collagen matrix outside the cells. 
Because in this model particles could be found located both inside and outside the cells, we 
have named it “In&Out Model”. The presence of particles both inside the cells and within the 
collagen matrix has been verified by confocal microscopy (Fig. 3). Interestingly, two 
different cell populations have been identified by flow cytometry: one population of cells 
with particles (58 ± 5%) and the other without particles (42 ± 8 %), indicating a slower rate 
of MNP uptake when compared to the In Model for the same incubation time of 1 h (Fig. 3), 
probably due to the time required for the movement of the MNPs towards the inner parts of 
the 3D structure. One of the advantages of using these two 3D cell culture models is that, 
although the same amount of particles has been administered to the cells, we have been able 
to achieve two different kinetic behaviours of MNP internalization.
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8Fig. 3. 3D cell culture characterization (A, B, C, D) Confocal images. The nucleus is shown 
in blue (DAPI), actin in green (Phalloidin_AlexaFluor488) and MNPs in red (TAMRA). Scale 
bar: 10 µm. (E, F, G, H) Flow cytometry analysis of nanoparticle uptake. Data have been 
selected as a representation of a series of five experiments.
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9AMF exposure enhances MNP uptake. Once it has been verified that the two models were 
successfully generated, the transformations that may occur with time have been evaluated. In 
particular, the capacity of the cells to continue internalizing MNPs in the In&Out Model has 
been assessed. To evaluate the time frame of the MNP uptake in the In&Out Model, the 
evolution with time of the two different cell populations previously observed by flow 
cytometry (with and without MNPs) has been measured (Table 1). Results have been 
compared also with 3D cell cultures of the In&Out Model after the AMF exposure to evaluate 
its impact on the MNP uptake.
The percentage of cells that contain MNPs in the In&Out Model increases with time, 
reaching a point at 24h after their addition where all cells contain MNPs (Fig. 4). This uptake, 
however, is significantly faster in the 3D cell cultures exposed to the AMF. It has been 
observed that immediately after the AMF exposure, a higher percentage of cells had uptaken 
MNPs (70 ± 3 %) in comparison with the control experiment with no AMF exposure in 
which only 58 ± 4 % of the cells showed MNP internalization. In addition, 3 h after the 
administration of the MNPs, the two populations of cells (with (69 ± 4 %) and without (31 ± 
4 %) particles) were still observed in the 3D cell culture that had no exposure to the AMF 
while almost all the cells exposed to the AMF (99 ± 0.5 %) had uptaken MNPs. Nevertheless, 
although all the cells from the In&Out Model contain MNPs 24 h after the 3D cell culture 
generation, still many particles remain located outside the cells within the collagen fibres as 
observed by confocal microscopy (Fig. 5). As a conclusion of these results, flow cytometry 
studies in the In&Out Model demonstrate an enhancement in the rate of the MNP uptake by 
the cells triggered by AMF exposure (Fig. 4). 
Time pointsExperimental 
conditions 0 h 3 h 24 h
-AMF 58 ± 4 % 69 ± 4 % 99.5 ± 0.3 %
+AMF 70 ± 3 % 99 ± 0.5 % 99.2 ± 0.6 %
Table 1. Percentage of cells that contain MNPs in the In&Out Model at different time 
points, either in the control experiment with no AMF exposure (-AMF) or after the AMF 
exposure (+AMF). Data obtained by flow cytometry (n=5).
Page 9 of 43
ACS Paragon Plus Environment
ACS Applied Materials & Interfaces
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
10
Fig. 4. Flow cytometry analysis of the time dependent nanoparticles uptake in the In&Out 
Model. Left: Cells without exposure to the AMF (-AMF), Right: Cells after the AMF 
exposure(+AMF). (A, E) Control cells without MNP, (B, F)  0 hours, (C, G) 3 hours, (D, H) 
24 hours. Data have been selected as a representation of a series of five experiments.
Page 10 of 43
ACS Paragon Plus Environment
ACS Applied Materials & Interfaces
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
11
Fig. 5. 3D reconstruction of confocal images acquired for the In&Out Model 24 h after 
AMF exposure. The nucleus is shown in blue (DAPI), actin in green 
(Phalloidin_AlexaFluor488) and MNPs in red (TAMRA). The presence of MNPs is still 
observed outside the cells 24 h after the AMF exposure.
To further investigate the mechanisms behind this MNP internalization enhancement 
mediated by AMF exposure, two 3D cell cultures of the In&Out Model have been prepared, 
and one of them has been exposed to the AMF. Images of the whole 3D structure have been 
acquired for the initial time point (Fig. 6). In the case of the cell culture not exposed to the 
AMF, most of the particles have not been able to diffuse towards the inner part of the 
collagen matrix, being mainly localized in the outer areas of the 3D structure. However, in 
the cell culture exposed to the AMF, particles have penetrated better and are more 
homogeneously distributed throughout the whole 3D structure. This phenomenon of a more 
uniform distribution of MNPs after the AMF exposure has also been previously observed in a 
spheroid model of triple negative breast cancer.34 It has also been previously reported on a in 
vivo model where the nanoparticles where initially located in the collagen-rich outer areas of 
the tumour and penetrated more deeply into the core after the hyperthermia treatment.47
The enhancement of the MNP uptake may be associated with an increase in collagen 
permeability induced by the temperature rise during the MH treatment making the MNPs 
more “accessible” to the cells. It is known since a long time that the melting temperature of 
the triple helixes of the collagen type I, which is the most abundant in the nature, is few 
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degrees above body temperature.48 Most recent studies have shown that the denaturation of 
the collagen vitrified gels takes place in two steps: a reversible process that results in a meta-
stable collagen matrix, and an irreversible process that takes place at 60 ºC, leading a random 
uncoiled collagen.49 These results are relevant for the design of future preclinical treatments, 
as collagen is one of the major components of the tumour extracellular matrix present in 
breast,50 prostate,51 glioma,52 or pancreatic53 cancer. Therefore, the benefits of the  
application of periodical cycles of AMF exposure would be to improve the permeability of 
the extracellular matrix and therefore the access of chemotherapeutic drugs or cells from the 
immune system to the inner areas of the tumour. In addition, the enhancement of the 
internalization of MNPs after each cycle could positively influence subsequent hyperthermia 
cycles and this amplification effect could have positive synergetic effects in the final 
effectiveness of the treatment. 
Fig. 6. Map image of confocal microscopy of 3D cell culture without (A) and with (B) the 
AMF exposure for the In&Out Model (0 hours). The image shows the overlay of two 
channels: green fluorescence of the labeled cells and red fluorescence of the MNPs. Scale 
bar is 500 µm.
Magnetic Hyperthermia treatment induces different cell death mechanisms in the two 
3D cell culture models. To evaluate the effect of the differences between the two models on 
the cell death mechanisms we have evaluated the activation of the cell death routes at three 
different time points (0, 24 and 48 h) after the hyperthermia treatment. Interestingly, the 
results have shown differences in the cell death mechanism between the two models. Just 
Page 12 of 43
ACS Paragon Plus Environment
ACS Applied Materials & Interfaces
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
13
after the hyperthermia treatment (0 h) most of the cells remain alive in both models, being 
negative for Propidium Iodide (PI) and Annexin V staining. PI is a small molecule that enters 
in the cells and binds DNA only when the lipid bilayer membrane is disrupted, which 
happens in the late stages of the apoptosis and in the necrosis mechanism. Annexin-V binds 
phosphatidylserine (PS), a phospholipid that is normally located on the inner side of the cell 
membrane but translocates to the extracellular side in the first stage of the apoptosis. 
Therefore, cells that are positive for PI and negative for Annexin V have their cell membrane 
integrity altered without exposing the phosphatidylserine, a process typical from the 
beginning of necrosis, while cells that are positive for both markers indicate a late necrosis or 
late apoptosis stage.54 
One day after the treatment, the In Model shows a significant population of necrotic cells 
(39.02 ± 4%) (positive for PI and negative for Annexin V), 60.09 ± 4.5% of cells that are still 
alive (negative for both markers) and a small percentage of cells (0.89 ± 0.1%) that are 
probably in a late necrosis stage (positive for both markers). On the contrary, at 24 h, the 
In&Out Model presents a very different situation where 38 ± 5.6% of the cells are undergoing 
apoptosis (positive for Annexin V and negative for PI) and the rest of the cells (61 ± 5.8%) 
are alive (Fig. 7). As a conclusion we can say that the In&Out Model results in a more 
controlled cell death pathway while the response to the MH treatment in the In Model is more 
aggressive. 
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14
Fig. 7. Analysis of magnetic hyperthermia-induced cell death (Annexin V and PI staining). 
Selected density plot (representative of 5 experiments) obtained at 0h and 24h after MH 
treatment for the In Model (A) and In&Out Model (B). (C and D) Summarized flow cytometry 
data resulting from five independent experiments shown as mean ± SD. Statistical 
significance between the means at the different times was determined using a two-way 
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ANOVA with Sidak's multiple comparisons test (**** p < 0.0001; *** p < 0.001; p > 0.05 no 
significance). 
To evaluate the status of the cells that remain alive 24 h after the treatment, the cell cycle has 
been analysed by flow cytometry (Fig. 8). It has been previously shown that among the 
crucial events triggered by a heat shock stress are the changes in the cell cycle progression. 
Depending on the duration and the intensity of the heat shock, cells can enter into a transient 
or permanent cycle arrest that can take place either in the G1 or G2/M transition. Cells 
accumulate at these so-called checkpoints because the activity of the proteins that regulate 
these transitions (cyclin-dependent kinases) decreases.55 G1 checkpoint checks several 
aspects of the cells such as the size, nutrients and DNA damage before entering in the 
replication phase, and G2 checkpoint is focused on analysing DNA damage after the 
replication and replication completeness. So, depending when the DNA damage occurs the 
cells will be arrested in different phases. Previous results have shown that mild heat shock 
provokes a cell-cycle arrest in the G2/M phase.56
Cell cycle analysis of the control 3D cell culture has revealed that around 40% of cells are in 
the G2M phase in both models. This phase includes both cells undergoing the G2 phase, 
where cells prepare themself for mitosis, and also those cells that are dividing (M phase).57 
The observation of an important percentage of cells in this sub-phase suggests a normal 
replication of the cells after the 3D model construction. In contrast, the analysis of the cell 
cycle from the cells that remained alive 24 h after the MH treatment for both models has 
revealed a significant decrease on the percentage of cells in the G2M and S phases, 
accompanied by an increase on the percentage of cells in the G0/G1 phase. These results 
indicate an arrest of the cells in the G0/G1 phase that does not allow the cells to duplicate its 
DNA and undergo the mitosis process. Therefore, it can be concluded that cells are suffering 
damages that are being detected by the key proteins preventing the cell replication process. 
The arrest is however more pronounced for the In Model. This result is probably a 
consequence of the heterogeneous distribution of MNPs along the 3D structure of the In&Out 
Model when the AMF is applied, as the core of the 3D cell culture would probably contain 
cells that have not incorporated MNPs or that are far away from other extracellular MNPs 
that act as heating agents. However, in order to have a more detailed explanation of the 
mechanisms involved, further experiments on the expression and activity of some proteins 
such as p-53 and some cyclin-dependent kinases should be performed in future studies.
Page 15 of 43
ACS Paragon Plus Environment
ACS Applied Materials & Interfaces
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
16
It should also be briefly discussed that a small decrease in the percentage of cells in mitosis 
phase is observed in the In Model in comparison with the In&Out Model. This effect has been 
observed both in the model with cells incubated with MNPs and the control incubated 
without MNPs and is probably due to the protocol of the 3D model preparation. In the In 
Model, the cells have been maintained in suspension during 1 hour for the incubation period. 
As RAW–264.7 are adherent cells, the suspension step is less favourable for the normal cell 
development in comparison with the In&Out Model, where the cells are directly located into 
the collagen matrix. 
Fig. 8. Effect on cell cycle distribution 24 h after magnetic hyperthermia treatment. (A) In 
Model (B) In&Out Model. The distribution of cells in each phase is given in the case of no 
MH treatment (I); after MH treatment (II) and the comparison of both experiments (III). 
Results are represented as average ± S.D. and are based on three independent experiments. 
Statistical significance was determined using a one-way ANOVA with Bonferroni post-test 
(***p<0.001; **p<0.01; *p<0.05). 
To further evaluate the effects of the cell cycle arrest observed 24 h, the experiment was 
extended and the number of dead cells was determined by flow cytometry up to 48 h after the 
MH treatment for both models. A significant decrease on the number of cells alive is 
observed in both models at 48 h, presenting only ≈ 4% viability (Fig. 9). Despite the fact that 
different cell death routes are followed, these results indicate that the hyperthermia treatment 
is able to kill most of the cells just 48 h after the treatment. 
Page 16 of 43
ACS Paragon Plus Environment
ACS Applied Materials & Interfaces
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
17
Fig. 9. MNPs cell viability evaluated in 3D models at different times after the Magnetic 
Hyperthermia treatment. (A) In Model and (B) In&Out Model. Cell viability has been 
evaluated by Flow Cytometry for the two models and compared different controls: with 
(+MNPs) or without (-MNPs) magnetic nanoparticles, and with (+AMF) or without (-AMF) 
exposure to the magnetic field. Results from five independent experiments are shown as mean 
± SD. Statistical significance between the means respect to the control (-MNP -AMF) was 
determined using a two-way ANOVA with Dunnett's multiple comparisons test 
(****p<0.0001; ***p<0.001; **p<0.01; *p≤0.05; p>0.05 no significance). In cases where 
more than one group generated significant differences with respect to control, the means 
between those groups were also compared.
Magnetic Hyperthermia treatment induces different cell death mechanisms depending 
on the intracellular amount of MNPs. An important factor to take into account in the 
discussion of the previously shown results is that although the cells from both models have 
been incubated with the same amount of MNPs, due to the way the 3D models are prepared, 
cells from the In Model end up incorporating a higher amount of MNPs. To evaluate the 
amount of MNPs uptaken by the cells in both models, cells have been removed from the 
collagen structure and their iron content has been quantified (Table. S2, Supporting 
Information). When administering 100 μg of iron to both models, the intracellular iron 
content has been determined to be 10-fold higher for the In Model (8.7 x 10-8 mg Fe/cell) in 
comparison with the In&Out Model (8.1 x 10-9 mg Fe/cell) (see Fig. 10). This difference has 
been also verified after performing a magnetic characterization of the 3D cell cultures (See 
Fig. S4, Supporting Information).
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It is important to highlight that these values of iron uptake confirm the high amount of MNPs 
that macrophages are able to internalize (depending on the incubation conditions). It is also 
worth mentioning that the amount of internalized MNPs in the In&Out Model is of the same 
order as the observed in other cell lines 58-59 validating the interest of our model as a tool to 
better understand the cellular mechanisms triggered after the AMF exposure.
Several 3D cell cultures of the In Model have been prepared using decreasing amounts of 
MNPs to assess the iron amount internalized by the cells (Fig. 10). Our findings show that it 
is necessary to decrease 10 times the amount of iron added to the cells in the In Model in 
order to achieve an intracellular amount of MNPs of the same order of magnitude (1.8 x 10-8 
mg Fe/cell) as for the In&Out Model (Fig. 10) prepared with the highest MNPs concentration. 
In order to evaluate the effect of the iron content on the cell death mechanism in the In 
Model, macrophages incubated with 10 times less MNPs than in the previous experiments 
have been placed in a 3D matrix (In Model-lowFe) and exposed to the AMF. In such 
scenario, 24 hours after the treatment, 50% of the cells are undergoing an early apoptotic 
death, 35% of cells are in a late apoptosis/necrosis stage and 15% of cells remain alive (Fig. 
10). These results indicate a strong influence of the MNP concentration inside the cells on the 
cell death mechanism triggered by the MH treatment, as a higher MNP concentration triggers 
a necrotic pathway (Fig. 7) while the lower MNP concentration triggers an apoptotic 
pathway. 
Fig. 10. Effect of the iron concentration inside the cells. (A) Intracellular iron content for 
both 3D models as a function of the administered iron amount. (B) Flow cytometry analysis 
of the cells in the In Model-lowFe (incubated with 10 times less MNPs) 24 h after MH 
treatment. 
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It is important to highlight that the amount of MNPs internalized by the cells is able to 
modulate the cell death mechanism after the exposure to an AMF. However, we are still far 
from the complete control of the treatment. Some studies that compare the heating capacity of 
different MNPs when they are either in suspension or inside the cells, have shown a clear 
reduction of the SAR values when the MNPs are located in cellular vesicles.60 However, a 
non-monotonic relationship between MNP concentration and their heating capacity has been 
recently described.61 The MNPs heating performance as a function of their packing density is 
a complex scenario where several factors (interactions,61 viscosity of the medium,62 collective 
behaviour, etc.) are responsible of causing either an increase or a decrease of the MNP 
heating capacity when decreasing the MNP concentration. Given that determining the local 
concentration produced as a result of the strong agglomeration of the MNPs within the cell is 
a complicated task, it is difficult to make predictions about the impact of the different doses 
on the resulting heating effects for an specific kind of material.
To evaluate the effect of such possible differences of the MNPs aggregation could have on 
their heating capacities, and therefore on the cell death mechanism triggered, the magnetic 
properties of both 3D models prepared with the higher concentration of MNPs have been 
measured, prior to any AMF exposure. The AC magnetic susceptibility in the 10–200 K 
temperature range has been measured for both models as this kind of measurements is able to 
detect the effect of dipolar interactions caused by local aggregation (when particles are 
closely packed, interparticle distances decrease and the dipolar interactions among particles 
increase).63 Both samples display the characteristic features of the presence of 
superparamagnetic particles with a maximum in the in-phase susceptibility maxima 
accompanied by an out-of-phase susceptibility maximum at slightly lower temperatures.64 
The temperature dependence of the out-of-phase susceptibility, χ’’ (T), shows a maximum 
located at slightly different temperatures for both models (Fig. 11). Still, the differences 
observed in these two models do not justify a significant different MNP aggregation degree 
that could lead to different heating properties.61 These results are in agreement with previous 
studies evaluating the aggregation of MNPs in macrophage models that had shown negligible 
dipolar interactions among particles even during intracellular MNP aggregation.46 
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Fig. 11. Magnetic characterization of the 3D cell cultures. Temperature dependence of the 
out-of-phase susceptibility scaled to their maximum of the two different models.
The heterogeneous distribution of the magnetic nanoparticles within the 3D structure 
affects the rate of cell death. To evaluate the importance of the model on the MH treatment 
effect, the cell death rate observed for the In Model-lowFe has been compared with the 
In&Out Model (having a similar amount of internalized MNPs). In such scenario, although in 
both cases an apoptotic cell death mechanism is triggered, the rate of cell death is higher for 
the In Model-lowFe than for the In&Out Model. This is probably a consequence of the 
heterogeneous distribution of the MNPs amongst all the cells. It has been previously shown 
that, in the In&Out Model before the AMF exposure most of the MNPs are located at the 
outer areas of the 3D collagen structure (Fig. 6) and a significant number of cells do not 
contain any MNPs (Fig. 4). Therefore, only those cells containing MNPs and/or located in the 
outer areas of the 3D structure would feel the effect of the temperature increase, leading to a 
slower death rate. From all these results we can conclude that, even with a similar average 
amount of iron per cell, both models respond differently to the AMF exposure because of the 
initial location of the MNPs within the 3D structure.  
These results highlight the importance of the development of 3D cell culture models that 
mimic the complex scenario of a tissue with inhomogeneous MNPs distributions. It can be 
foreseen that the results from studies in 2D cell cultures are probably providing misleading 
results that do not relate to the effect of the hyperthermia treatment as a consequence of the 
different incorporation of the MNPs by the cells. Furthermore, our results indicate that 
repetitions of the AMF exposure, once the MNPs are more homogeneously distributed 
throughout the 3D structure, or a delay between the MNPs administration and the AMF 
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application to achieve a better distribution of the particles may result in a more effective 
treatment in vivo. 
Conclusions
We have prepared two different 3D cell models using a collagen matrix to mimic different 
possible tumour scenarios. In both models, cells have been exposed to the same amount of 
nanoparticles, however, while in the In Model, the MNPs are only located inside the cells and 
homogeneously distributed amongst all of them, in the In&Out Model a heterogeneous 
distribution is achieved with particles heterogeneously distributed outside the cells and also 
cells with and without MNPs.
The time dependence of the MNP uptake on the In&Out Model has been evaluated. At the 
initial time point, most of the MNPs are located in the outer areas of the 3D structure and 
therefore not all the cells have incorporated MNPs. Then, after 24h, all the cells from the 3D 
cell culture show the presence of MNPs inside their cytoplasm. In addition, it has been 
observed that this process of MNP uptake with time is faster after the exposure to the 
alternating magnetic field. These results are crucial for the design of in vivo hyperthermia 
treatments, as a delay between the MNP administration and the AMF exposure, or repeated 
cycles of AMF exposure, may improve the treatment effectiveness.
Our results demonstrate that MH induces the change in the collagen matrix that results in a 
more homogeneous distribution of the particles within the 3D cell culture. This observation 
may be of great relevance to use magnetic hyperthermia as a tool to disrupt the tumours 
extracellular matrix and improve the effect of other cancer treatments that have limitations to 
cross this barrier.
The development of these two different 3D models has allowed us to evaluate the effect of 
the nanoparticles concentration on the cell death mechanisms after the AMF exposure. In the 
In Model, that contains a higher amount of internalized MNPs, the main cell death 
mechanism observed 24 h after the MH treatment is necrosis, while in the In&Out Model and 
the In Model-Low Fe (containing a similar amount of MNPs as the In&Out Model) only 
apoptosis is observed at the same time point.
We have proved that the way MNPs are administered to the tumour area has a strong impact 
on the cell death mechanisms activated after the application of an AMF. MNPs 
administration route affects both the nanoparticle location within the 3D structure and 
concentration inside the cells and the accurate control of these two parameters is fundamental 
to develop an efficient and safe hyperthermia cancer treatment.
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We believe that the development of these two 3D models, will have a strong impact in the 
study of other therapies based on magnetic nanoparticles, such as their use in photothermal 
therapies using laser sources.60 However, several aspects such as the depth of the light 
penetration need to be optimized before.
Methods
Magnetic nanoparticle synthesis, functionalization and characterization 
Iron oxide MNPs were synthesized by thermal decomposition in organic media based on a 
previously reported seed-mediated growth method65 using iron (III) acetylacetonate 
(Fe(acac)3) as a precursor.44 This procedure rendered oleic-acid coated hydrophobic MNPs 
that were then transferred to water using a protocol based on the conjugation of the oleic acid 
with a hydrophilic polymer (poly(maleic anhydride-alt-1-octadecene, PMAO, MW 30000–
50000 Da) modified with TAMRA (tetramethylrhodamine 5(6)-carboxamide cadaverine 
(Anaspec, Seraing, Belgium), a fluorophore that allows the in vitro tracking of the MNPs.44  
Then, the coated MNPs were functionalized with glucose to provide further stability in 
biological media. The coated nanoparticles (1 mg of iron) were incubated with 42 μmol of N-
(3-dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC) and 30 μmol of 4-
aminophenyl β-D-glucopyranoside in 250 µL of SSB buffer (50 mM of boric acid and 50 mM 
of sodium borate) at pH 9. After 3 h at room temperature, the excess of reagents was removed 
by washing the sample with phosphate-buffered saline buffer (PBS) at pH 7.4 in a centrifugal 
filter.2 Finally, nanoparticles were passed through syringe filters with a pore size of 0.22 µm 
(Merck Millipore, Darmstadt, Germany). 
Dynamic light scattering and -potential measurements were performed in water and in 
complete Dulbecco’s Modified Eagle’s Medium GlutaMAX™ Supplement (cDMEM; 
Gibco®, Thermo Fisher Scientific) on a Malvern Zetasizer Nano-ZS, using ten runs per 
measurement and five replicates at 25 °C and pH 7. 
Particle size and morphology were studied by Transmission Electron Microscopy (TEM) 
using a Tecnai T20 (FEI company, OR, USA) microscope operating at 200 kV. The sample 
was prepared by placing a drop of a diluted suspension of the MNPs in water onto a carbon-
coated grid and allowing it to dry. Particle size was determined by manual measurement of 
200 particles using the Digital Micrograph software.
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The heating capacity of the MNPs was determined using a commercial Alternating Magnetic 
Field generator (DM100; Nanoscale Biomagnetics, Spain). A 1 mg Fe/mL MNP sample was 
placed in a closed container centred in the inductive coil. The AMF was applied for 5 min 
using a field amplitude of H = 20 kA/m, and a frequency of 829 kHz while the temperature 
was recorded using an optic fiber sensor incorporated in the equipment.
For the magnetic characterization, the MNPs liquid sample was allowed to dry at room 
temperature deposited into a piece of cotton wool that was subsequently placed into a gelatine 
capsule. Field dependent magnetization measurements were performed in a Quantum Design 
(USA) MPMS-XL SQUID magnetometer at 300 K with a maximum field of 5 T. 
Sterility assay
Swab and Samplers Test Kits (Merck Millipore) were used for the quality control of the 
MNPs sterility. The microbiological analysis aimed at detecting bioburden levels of bacteria, 
yeast or mold (Coli-Count™, Heterotrophic Plate Count and Yeast and Mold Samplers). The 
MNPs were tested in the sampler membrane, covered with growth medium for specific 
microorganism, at the common dilution used for the in vitro studies following the incubation 
conditions specified by the manufacturer (Coli-Count 35 °C, 22-24 h; Yeast and Mold 28-32 
°C, 48-72 h; Heterotrophic Plate Count (HPC) Sampler 25-35 °C, 48-72h). After the 
incubation, the filter surface was examined with an illuminator to identify the presence of 
microbial colonies. 
Cell line 
The murine macrophage RAW–264.7 cell line (ATCC® TIB71™) was cultured and 
maintained in cDMEM supplemented with 10 % fetal bovine serum (FBS, Invitrogen), 100 
U/mL penicillin G (sodium salt) and 100 μg/mL streptomycin sulfate (Invitrogen) at 37 °C in 
a humidified atmosphere at 5 % CO2. To detach the cells, a two-step protocol was followed 
trying to enhance the cells viability. First, cells were incubated with Trypsin EDTA solution 
(Sigma Aldrich) for 5 minutes at 37 ºC and then, the cells were scrapped from the flask. 
Finally cells were collected in fresh cDMEM. 
Formation of 3D cell culture models 
3D cell culture gels were prepared as follows. First, 250 μL of a 4x106 cells/mL suspension in 
complete culture medium were mixed with fetal bovine serum (Invitrogen) and Modified 
Eagle’s Medium 10x (MEM w/Earle´s salts, w/o Glutamine, w/o Sodium Bicarbonate, First 
Link UK Ltd) in a 1:1:1 volumetric ratio. The resulting cell suspension was added to an ice-
cold mixture of 1.25 mL rat tail Collagen type I (Protein concentration 2.05 mg/mL in 0.6 % 
acetic acid, First Link UK Ltd) solution and 0.5 mL 0,1 % sodium hydroxide (NaOH) 
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solution. Then, some drops of NaOH were added while gently shaking until the medium 
turned pink. After that, the final mixture was added quickly to a 24 well plate (600 μL / well, 
≈ 106 cells / well, Thermo Scientific Nunc Cell-Culture) and incubated at 37 °C for 30 min. 
After collagen gellification, 0.5 mL of complete culture medium was added per gel.
Two different strategies for the incubation with magnetic nanoparticles were followed. The 
first model where nanoparticles are located only inside the cells - In Model- was prepared by 
incubating detached cells (4x106 cells/mL in complete medium) with the MNPs (0.2 
mgFe/mL) during 1 h at 37 ºC and then washing the particles that had not been uptaken by 
centrifugation (161 rcf, 6 min) twice. After that, the cells were used to form the collagen gel. 
The second strategy produced the 3D cell culture where the particles are located both inside 
and outside the cells - In&Out Model, and also have a heterogeneous localization within the 
3D structure. To achieve this, the 3D model containing the cells was formed as described 
before. Just after collagen solidification, 500 μL of a MNP solution of 0.2 mg Fe/mL in 
complete medium were added and incubated at 37 °C for 1 h. After that, the supernatant was 
removed, the 3D cell culture was washed twice, and 500 μL of complete culture medium 
were added to the 3D model. 
MNPs toxicity.
2D cell cultures were incubated during 1 h with increasing amounts of iron (10, 20 50, 100 
and 200 μg) prepared in a final volume of 500 μL. 3D cell cultures were incubated with 100 
μg of iron during 1 h. Cell viability was assessed by flow cytometry.
Magnetic Hyperthermia treatment
Before starting the AMF exposure and during the treatment, 3D cell cultures were 
thermalized at 37 °C using a water bath pump (Stryker - Medical Devices & Equipment 
Manufacturing Company) connected to a water tubing jacket. Then, the 3D cell cultures were 
exposed to an AMF during 30 min at a frequency of 377.5 kHz and field amplitude of 13 
kAm-1 using a commercial AMF generator (DM3, nB nanoscale Biomagnetics, Zaragoza, 
Spain). 
Flow cytometry studies
Cells were released from the 3D cell cultures using a treatment with collagenase type I 
(isolated from Cl. histolyticum lyophilized, non-sterile, Gibco™ Thermo Fisher Scientific) at 
2 mg/mL in HBSS (Hank's Balanced Salt Solution) during 30 min at 37 ºC. Then, cells were 
washed by centrifugation (161 rcf, 6 min) and re-suspended in PBS (Phosphate Buffer Saline 
pH=7.4). All samples were analysed in a Gallios™ Flow Cytometer (Beckman Coulter) and 
the data interpreted with Kaluza 1.5a Software (Beckman Coulter). 
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To determine the MNPs uptake, cells re-suspended in PBS at a concentration of 2.5x104 
cells/mL were  analysed by flow cytometry. 
To study the cell viability, cells were re-suspended in 1X Annexin V Binding Buffer (10 mM 
Hepes/NaOH (pH=7.4) 140 mM NaCl, 2,5 mM CaCl2) at a concentration of 106 cells/mL. 
Then, 5 μl of the Annexin V-FITC (Fluorescein Isothiocyanate) and 5 μL of Propidium 
Iodide (PI) were added to 100 µL of cell suspension and incubated at room temperature for 
15 minutes in the dark (FITC-Annexin V Apoptosis Detection Kit). After the incubation 
period, 400 μL of 1X Annexin binding buffer was added and the sample was analysed by 
flow cytometry. 
To evaluate the cell cycle, cells were fixed with cold ethanol (70%) during 24 h and, after 
that, incubated with propidium iodide during 30 min in dark for analysis by flow cytometry. 
The data obtained was treated with the MODFIT LT 3.0 Verity Software (G0/G1, G2/M and 
S indicate the cell cycle phase while sub-G0/G1 refers to the proportion of apoptotic cells.) 
Confocal microscopy
To study the MNP internalization, the 3D cell cultures were fixed during 20 min with 500 µL 
of paraformaldehyde (4%). Then, the nuclei were stained with DAPI (4′,6-diamidino-2-
phenylindole) and the cytoskeleton with Phalloidin488. An Olympus FV10i Confocal Laser 
Scanning Microscope equipped with 405 nm (18 mW), 473 nm (12.5 mW) and 635 nm (10 
mW) lasers was used to acquire images of the cells. The images were then processed using 
Olympus Fluoview FV10-ASW 3.1 Viewer software (Olympus Canada, Markham, ON, 
Canada). The three dimensional projection images of the 3D cell cultures were obtained with 
a Zeiss LSM 880 Confocal Microscope with a 63x/1.40 Plan Apochromat objective. The 
laser sources used were 458 nm, 488 nm (Argon Ion), 561 nm (DPSS- Diode-pumped solid 
state). ZEN Microscope and Imaging Software were used for the image analysis.
Magnetic characterization
3D cell cultures were freeze-dried and placed into gelatine capsules for their magnetic 
characterization. AC (alternating current) magnetic susceptibility measurements were 
performed in a Quantum Design (USA) MPMS-XL SQUID magnetometer with an AC 
amplitude of 0.41 Oe, in the temperature range between 10 and 200 K and at a frequency of 
11 Hz.
Iron quantification
Iron concentration was determined using a standard colorimetric procedure.66 For the MNPs, 
an aliquot was digested with aqua regia for 15 min at 60 °C and diluted with Milli-Q water. 
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For the cells, 3D cell cultures were treated with collagenase (2 mg/mL) 30 min at 37 °C and 
after that the cells were spun down in a mini spin centrifuge. The digestion of the cells was 
performed heating with HNO3 (Panreac) and then with H2O2 (Panreac) (both steps at 90ºC 
and during 1 h each). A calibration curve was prepared by dilution of an Iron standard 
solution 1 mg/mL Fe in 2% HNO3 (Acros Organics, USA). The digested samples were 
incubated at room temperature for 15 min after the addition of KOH (4 N), 4,5-dihydroxy-
1,3-benzenedisulfonic acid disodium salt monohydrate (Tiron) and sodium phosphate buffer 
(0.2 M pH=9.7). Finally, sample absorbance (480 nm) was measured on an UV/Vis 
spectrophotometer (Thermo Scientific Multiskan™ GO MA, USA) and compared to a 
calibration curve. 
Statistical analysis
Data are expressed as mean ± SD of a minimum three biological replicas. Statistical 
significance of difference in means was performed using GraphPad Prism v7.00 Student´s 
test and one-way ANOVA test were used for the analysis of the data. The confidence interval 
was 95%. Bonferroni post-test was used to determine which means differed.  
Associated content
Complementary results are supplied as Supporting Information:
Table S1. Hydrodynamic size and ζ – potential of magnetic nanoparticles.
Table. S2. Iron concentration located inside the cells.
Fig. S1. Sterility assay.
Fig. S2. MNPs toxicity assay in 2D cell cultures.
Fig. S3. MNPs toxicity evaluated in 3D models.
Fig. S4. Magnetic characterization of the 3D models.
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 Fig. 1. Representation of the formation of the two 3D models used in this work. In Model, where the MNPs 
are located just inside the cells. In&Out Model, where MNPs are  located both inside and outside the cells. 
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 Fig. 2. Magnetic nanoparticle characterization. (A) TEM micrograph, (B) Particle size distribution analysis and 
(C) Field dependent magnetization of the MNPs in water. 
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 Fig. 3. 3D cell culture characterization (A, B, C, D) Confocal images. The nucleus is shown in blue (DAPI), 
actin in green (Phalloidin_AlexaFluor488) and MNPs in red (TAMRA). Scale bar: 10 µm. (E, F, G, H) Flow 
cytometry analysis of nanoparticle uptake. Data have been selected as a representation of a series of five 
experiments. 
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 Fig. 4. Flow cytometry analysis of the time dependent nanoparticles uptake in the In&Out Model. Left: Cells 
without exposure to the AMF (-AMF), Right: Cells after the AMF exposure(+AMF). (A, E) Control cells without 
MNP, (B, F)  0 hours, (C, G) 3 hours, (D, H) 24 hours. Data have been selected as a representation of a 
series of five experiments. 
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 Fig. 5. 3D reconstruction of confocal images acquired for the In&Out Model 24 h after AMF exposure. The 
nucleus is shown in blue (DAPI), actin in green (Phalloidin_AlexaFluor488) and MNPs in red (TAMRA). The 
presence of MNPs is still observed outside the cells 24 h after the AMF exposure. 
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 Fig. 6. Map image of confocal microscopy of 3D cell culture without (A) and with (B) the AMF exposure for 
the In&Out Model (0 hours). The image shows the overlay of two channels: green fluorescence of the 
labeled cells and red fluorescence of the MNPs. Scale bar is 500 µm. 
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 Fig. 7. Analysis of magnetic hyperthermia-induced cell death (Annexin V and PI staining). Selected density 
plot (representative of 5 experiments) obtained at 0h and 24h after MH treatment for the In Model (A) and 
In&Out Model (B). (C and D) Summarized flow cytometry data resulting from five independent experiments 
shown as mean ± SD. Statistical significance between the means at the different times was determined 
using a two-way ANOVA with Sidak's multiple comparisons test (**** p < 0.0001; *** p < 0.001; p > 0.05 
no significance). 
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 Fig. 8. Effect on cell cycle distribution 24 h after magnetic hyperthermia treatment. (A) In Model (B) In&Out 
Model. The distribution of cells in each phase is given in the case of no MH treatment (I); after MH 
treatment (II) and the comparison of both experiments (III). Results are represented as average ± S.D. and 
are based on three independent experiments. Statistical significance was determined using a one-way 
ANOVA with Bonferroni post-test (***p<0.001; **p<0.01; *p<0.05). 
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 Fig. 9. MNPs cell viability evaluated in 3D models at different times after the Magnetic Hyperthermia 
treatment. (A) In Model and (B) In&Out Model. Cell viability has been evaluated by Flow Cytometry for the 
two models and compared different controls: with (+MNPs) or without (-MNPs) magnetic nanoparticles, and 
with (+AMF) or without (-AMF) exposure to the magnetic field. Results from five independent experiments 
are shown as mean ± SD. Statistical significance between the means respect to the control (-MNP -AMF) 
was determined using a two-way ANOVA with Dunnett's multiple comparisons test (****p<0.0001; 
***p<0.001; **p<0.01; *p≤0.05; p>0.05 no significance). In cases where more than one group generated 
significant differences with respect to control, the means between those groups were also compared. 
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 Fig. 10. Effect of the iron concentration inside the cells. (A) Intracellular iron content for both 3D models as 
a function of the administered iron amount. (B) Flow cytometry analysis of the cells in the In Model-lowFe 
(incubated with 10 times less MNPs) 24 h after MH treatment. 
397x193mm (150 x 150 DPI) 
Page 42 of 43
ACS Paragon Plus Environment
ACS Applied Materials & Interfaces
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 Fig. 11. Magnetic characterization of the 3D cell cultures. Temperature dependence of the out-of-phase 
susceptibility scaled to their maximum of the two different models. 
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